AAAAAA
Results:
1-8
|
Results: 8
Authors:
JAMMERS EA
SCHILLING A
SPIESS C
KRANDA K
Citation: Ea. Jammers et al., EFFECTS OF HALOPERIDOL ON THE OXIDATIVE-METABOLISM IN HUMAN STRIATUM, European journal of neuroscience, 10, 1998, pp. 14805-14805
Authors:
PASS HI
TEMECK BK
KRANDA K
STEINBERG SM
FEUERSTEIN IR
Citation: Hi. Pass et al., PREOPERATIVE TUMOR VOLUME IS ASSOCIATED WITH OUTCOME IN MALIGNANT PLEURAL MESOTHELIOMA, Journal of thoracic and cardiovascular surgery, 115(2), 1998, pp. 310-317
Authors:
KRANDA K
HOROWSKI R
SCHUBERT F
SEIFERT F
Citation: K. Kranda et al., TRANSIENT APHASIA INDUCED BY THE ONSET OF MULTIPLE-SCLEROSIS, Journal of physiology, 511P, 1998, pp. 68-69
Authors:
PASS HI
TEMECK BK
KRANDA K
THOMAS G
RUSSO A
SMITH P
FRIAUF W
STEINBERG SM
Citation: Hi. Pass et al., PHASE-III RANDOMIZED TRIAL OF SURGERY WITH OR WITHOUT INTRAOPERATIVE PHOTODYNAMIC THERAPY AND POSTOPERATIVE IMMUNOCHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA, Annals of surgical oncology, 4(8), 1997, pp. 628-633
Authors:
PASS HI
KRANDA K
TEMECK BK
FEUERSTEIN I
STEINBERG SM
Citation: Hi. Pass et al., SURGICALLY DEBULKED MALIGNANT PLEURAL MESOTHELIOMA - RESULTS AND PROGNOSTIC FACTORS, Annals of surgical oncology, 4(3), 1997, pp. 215-222
Authors:
JOBERT M
KRANDA K
DUCHENE J
Citation: M. Jobert et al., PROCESSING VISUAL-EVOKED POTENTIALS BASED ON MATCHED FILTERING OF SINGLE TRIAL RESPONSES, Neuropsychobiology, 34(3), 1996, pp. 166-174
Authors:
PASS HW
TEMECK BK
KRANDA K
STEINBERG SM
PASS HI
Citation: Hw. Pass et al., A PHASE-II TRIAL INVESTIGATING PRIMARY IMMUNOCHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA AND THE FEASIBILITY OF ADJUVANT IMMUNOCHEMOTHERAPY AFTER MAXIMAL CYTOREDUCTION, Annals of surgical oncology, 2(3), 1995, pp. 214-220
Authors:
POGREBNIAK HW
WITT CJ
TERRILL R
KRANDA K
TRAVIS WD
ROSENBERG SA
PASS HI
Citation: Hw. Pogrebniak et al., ISOLATED LUNG PERFUSION WITH TUMOR-NECROSIS-FACTOR - A SWINE MODEL INPREPARATION OF HUMAN TRIALS, The Annals of thoracic surgery, 57(6), 1994, pp. 1477-1483
Risultati:
1-8
|